Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Opaleye, L.P. — Protara Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Opaleye, L.P.

Opaleye, L.P.

10% owner at Protara Therapeutics, Inc. · on record since Jan 13, 2020

Insider trading activity of Opaleye, L.P.

Transactions on record: 2; since Jan 13, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 13, 2020

Figures computed from official regulatory filings — methodology.

Companies where Opaleye, L.P. has traded

Protara Therapeutics, Inc.2 tx · $10M · Jan 13, 2020

Track record of Opaleye, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Opaleye, L.P.

Co-insiders of Opaleye, L.P.

Abingworth LLPProtara Therapeutics, Inc.
Bandari JathinProtara Therapeutics, Inc.
BESHAR LUKE MProtara Therapeutics, Inc.
Birner HubertProtara Therapeutics, Inc.
BOHLIN GAREN GProtara Therapeutics, Inc.
Braunstein ScottProtara Therapeutics, Inc.
Burke Steven KeithProtara Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Canute Scott AProtara Therapeutics, Inc.

Casoy JulioProtara Therapeutics, Inc.

CONKLING WILLIAMProtara Therapeutics, Inc.

Davis BlaineProtara Therapeutics, Inc.

Eldridge, George ArthurProtara Therapeutics, Inc.

Fabbio PatrickProtara Therapeutics, Inc.

Fischer StefanProtara Therapeutics, Inc.

Flannelly Barry PProtara Therapeutics, Inc.

Freund John GordonProtara Therapeutics, Inc.

Fry HannahProtara Therapeutics, Inc.

GARCEAU ROGERProtara Therapeutics, Inc.

Goll AlexandraProtara Therapeutics, Inc.

Gottlieb Daniel PhilipProtara Therapeutics, Inc.

Haines TimothyProtara Therapeutics, Inc.

Hartman Bradley JProtara Therapeutics, Inc.

HASTINGS PAUL JProtara Therapeutics, Inc.

Huang JaneProtara Therapeutics, Inc.

KANEKO YASUNORIProtara Therapeutics, Inc.

Kingsley Stuart AProtara Therapeutics, Inc.

Kobyzev DmitryProtara Therapeutics, Inc.

Kowalsky Matthew PaulProtara Therapeutics, Inc.

LEFF JONATHAN SProtara Therapeutics, Inc.

LEVY RICHARD SProtara Therapeutics, Inc.

Marshall RandallProtara Therapeutics, Inc.

Nicacio Leonardo VianaProtara Therapeutics, Inc.

NOYES TIMOTHY PProtara Therapeutics, Inc.

O'Leary BrendanProtara Therapeutics, Inc.

Olivo Martin SebastianProtara Therapeutics, Inc.

Opaleye Management Inc.Protara Therapeutics, Inc.

Pharmstandard International S.A.Protara Therapeutics, Inc.

PHELPS GREGORY DProtara Therapeutics, Inc.

Prism Venture Partners V-A LPProtara Therapeutics, Inc.

Prism Venture Partners V L PProtara Therapeutics, Inc.

Public Joint Stock Co PharmstandardProtara Therapeutics, Inc.

SARGEN GREGORYProtara Therapeutics, Inc.

SCHUHSLER HELMUTProtara Therapeutics, Inc.

Shefferman JesseProtara Therapeutics, Inc.

Skyline Venture Management IV, LLCProtara Therapeutics, Inc.

Skyline Venture Partners Qualified Purchaser Fund IV L PProtara Therapeutics, Inc.

Smith CynthiaProtara Therapeutics, Inc.

Solomon Michael EdwardProtara Therapeutics, Inc.

Toner E. ScottProtara Therapeutics, Inc.

TVM Life Science Ventures VI GmbH & Co KGProtara Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Protara Therapeutics, Inc.	Jan 13, 2020	Award	1,426,234	7.01 USD	$10M	SEC
Protara Therapeutics, Inc.	Jan 13, 2020	Award	777,635	—	—	SEC